Inventor · disambiguated record
Darren Disalvo
Also filed as: DISALVO DARREN · DISALVO DARREN TODD
16 granted patents·8 pending applications·127 citations·filing 2003–2019
93Inventor score
Files withBOEHRINGER INGELHEIM INT11BOEHRINGER INGELHEIM PHARMA6BOSANAC TODD2BENTZIEN JOERG MARTIN1BETAGERI RAJASHEKHAR1
Top patents by PatentIndex Score
24 records- 0192US7879873B2Azaindazole compounds as CCR1 receptor antagonistsBOEHRINGER INGELHEIM INT·Filed 2009·Granted Feb 1, 2011·22 cites·32 claims
- 0290US8940893B2Heteroaromatic compounds as BTK inhibitorsBOSANAC TODD·Filed 2014·Granted Jan 27, 2015·19 cites·10 claims
- 0389US7741361B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Jun 22, 2010·13 cites·8 claims
- 0489US7635711B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Dec 22, 2009·15 cites·5 claims
- 0588US10364255B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jul 30, 2019·6 cites·39 claims
- 0687US10875852B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 29, 2020·2 cites·12 claims
- 0786US8008327B2Indazole compounds as CCR1 receptor antagonistsBOEHRINGER INGELHEIM INT·Filed 2009·Granted Aug 30, 2011·8 cites·7 claims
- 0885US6974870B2Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their usesBOEHRINGER INGELHEIM PHAMACEUT·Filed 2003·Granted Dec 13, 2005·23 cites·5 claims
- 0982US10138229B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·2 cites·20 claims
- 1078US8658637B2Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofKUZMICH DANIEL·Filed 2007·Granted Feb 25, 2014·4 cites·4 claims
- 1175US7119102B2Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their usesBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Oct 10, 2006·6 cites·13 claims
- 1272US7550473B2Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jun 23, 2009·6 cites·13 claims
- 1369US10570118B2Isoquinolones as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Feb 25, 2020·1 cites·12 claims
- 1460US2014045813A1Heteroaromatic compounds as btk inhibitorsBENTZIEN JOERG MARTIN·Filed 2013·Application pending·0 cites
- 1559US2008312185A1SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USESCHEN ZHIDONG·Filed 2008·Application pending·0 cites
- 1659US2017320867A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 1757US2006270671A1Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their usesBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1854US2016031872A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1953US2019263828A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2052US2004242613A1Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 2149US2010048950A1Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses ThereofBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 2243US8895750B2Heteroaromatic compounds as BTK inhibitorsBOSANAC TODD·Filed 2014·Granted Nov 25, 2014·0 cites·16 claims
- 2335US9828364B2Pyrazole compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Nov 28, 2017·0 cites·7 claims
- 2432US8546442B2Pyrazolopiperidine compounds as CCR1 receptor antagonistsBETAGERI RAJASHEKHAR·Filed 2011·Granted Oct 1, 2013·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Darren Disalvo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →